• OPEN AN ACCOUNT
Indian Indices
Sensex
83,580.40 266.47
( 0.32%)
Global Indices
Nasdaq
50,145.69 1,215.96
(2.49%)
Dow Jones
6,954.50 135.10
(1.98%)
Hang Seng
54,176.23 358.19
(0.67%)
Nikkei 225
10,359.93 50.71
(0.49%)
Forex
USD-INR
90.32 -0.07
(-0.08%)
EUR-INR
106.52 -0.28
(-0.26%)
GBP-INR
122.68 -1.05
(-0.85%)
JPY-INR
0.58 0.00
(-0.33%)

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532989
INE878I01022
38.5638498
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BAFNAPH
25.95
274.41
EPS(TTM)
Face Value()
Div & Yield %
4.47
10
0
 

UTL Industries reports standalone net profit of Rs 0.04 crore in the September 2025 quarter
Nov 13,2025
Net profit of UTL Industries reported to Rs 0.04 crore in the quarter ended September 2025 as against net loss of Rs 0.01 crore during the previous quarter ended September 2024. Sales declined 33.33% to Rs 0.04 crore in the quarter ended September 2025 as against Rs 0.06 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.040.06 -33
OPM %100.00-16.67 -
PBDT0.04-0.01 LP
PBT0.04-0.01 LP
NP0.04-0.01 LP